T lymphocytes, natural killer cells, and antigen presentation function may be impaired in HNSCC patients due to upregulation of PD-1 and other immunological checkpoints receptor (ICR) molecules (11–14). The gene discussed is PDCD1; the disease is head and neck squamous cell carcinoma.